Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Clinical trial NCT01713283 · COMPLETED

Trial details

NCT number: NCT01713283
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Virus

Start date: 2012-10-01
Primary completion: 2013-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.